Study ID

200367

Clinical Study ID

200367

Study Title PGx6951: Analysis of influence of GLCCI1 variant rs37973 on inhaled corticosteroid response in COPD patients treated with fluticasone furoate in HZC112206 and HZC112207
Clinicaltrials.gov Identifier
Sponsor GlaxoSmithKline
Collaborators N/A
Phase N/A
Study Recruitment Status Completed
Generic Name fluticasone furoate
Trade Name Veramyst,Avamys,Allermist
Study Indication Pulmonary Disease, Chronic Obstructive

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.